Intravenous transplantation of amnion-derived mesenchymal stem cells promotes functional recovery and alleviates intestinal dysfunction after spinal cord injury.

导出 OA

翻译打印收藏纠错

作者： Soichiro,Takamiya ^[1] ; Masahito,Kawabori ^[1] ; Kazuyoshi,Yamazaki ^[1] ; Sho,Yamaguchi ^[2] ; Aki,Tanimori ^[1] ; Koji,Yamamoto ^[3] ; Shunsuke,Ohnishi ^[4] ; Toshitaka,Seki ^[1] ; Kotaro,Konno ^[5] ; Khin Khin,Tha ^[6] ; Daigo,Hashimoto ^[7] ; Masahiko,Watanabe ^[5] ; Kiyohiro,Houkin ^[1] ; Miki,Fujimura ^[1]

作者单位： Department of Neurosurgery, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan. ^[1] Regenerative Medicine and Cell Therapy Laboratories, Kaneka Corporation, Kobe, Hyogo, Japan. ^[2] Department of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan. ^[3] Laboratory of Molecular and Cellular Medicine, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido, Japan. ^[4] Department of Anatomy and Embryology, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan. ^[5] Global Center for Biomedical Science and Engineering, Hokkaido University Faculty of Medicine, Sapporo, Hokkaido, Japan. ^[6] Department of Hematology, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan. ^[7]